Sarissa Capital Management as of Sept. 30, 2025
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 8 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Innoviva (INVA) | 28.5 | $51M | 2.8M | 18.25 | |
| Neurocrine Biosciences (NBIX) | 23.6 | $43M | 303k | 140.38 | |
| Cytokinetics Com New (CYTK) | 17.9 | $32M | 588k | 54.96 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 11.6 | $21M | 16M | 1.31 | |
| Amarin Corp Sponsored Adr (AMRN) | 11.3 | $20M | 1.2M | 16.38 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 5.2 | $9.3M | 182k | 51.29 | |
| Regeneron Pharmaceuticals (REGN) | 1.3 | $2.4M | 4.2k | 562.27 | |
| Vor Biopharma Com New | 0.7 | $1.2M | 25k | 48.72 |
